Abstract
GRF, a specific stimulator of GH release, increased in a concentration- and time-dependent manner pituitary [3H]- arachidonate levels in vitro. This effect was antagonized by 100 nM somatostatin. Exogenous arachidonate also stimulated GH release in vitro. Quinacrine, a phospholipase A2 inhibitor, reduced both basal and GRF-stimulated free arachidonate levels as well as GH release. The cyclooxygenase inhibitor indomethacin was ineffective, while BW755c, which also inhibits the lipoxygenase pathway, produced a further increase in the levels of the fatty acid stimulated by GRF and potently reduced GH release. These results provide additional evidence for the involvement of arachidonate metabolism in the hormone-releasing effect of GRF at the somatotroph.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 267-272 |
Numero di pagine | 6 |
Rivista | Life Sciences |
Volume | 38 |
Numero di pubblicazione | 3 |
DOI | |
Stato di pubblicazione | Pubblicato - 20 gen 1986 |
Pubblicato esternamente | Sì |